329 related articles for article (PubMed ID: 32945455)
21. [Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway].
Xie YH; Chen XC; Zhang J; Huang TW; Song JQ; Fang YX; Pan XD; Lin ZY
Yao Xue Xue Bao; 2007 Aug; 42(8):828-32. PubMed ID: 17944229
[TBL] [Abstract][Full Text] [Related]
22. [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease].
Li X; Liu Y; Zhang X; Yuan H; Quan Q
Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3339-43. PubMed ID: 21438403
[TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice.
Li X; Huang L; Kong L; Su Y; Zhou H; Ji P; Sun R; Wang C; Li W; Li W
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36367174
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rg1 improves cognitive capability and affects the microbiota of large intestine of tree shrew model for Alzheimer's disease.
Guo Y; Wang L; Lu J; Jiao J; Yang Y; Zhao H; Liang Z; Zheng H
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33649817
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of ginsenoside Rg2 against memory impairment and neuronal death induced by Aβ25-35 in rats.
Cui J; Shan R; Cao Y; Zhou Y; Liu C; Fan Y
J Ethnopharmacol; 2021 Feb; 266():113466. PubMed ID: 33049344
[TBL] [Abstract][Full Text] [Related]
26. Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway.
Wu J; Pan Z; Wang Z; Zhu W; Shen Y; Cui R; Lin J; Yu H; Wang Q; Qian J; Yu Y; Zhu D; Lou Y
Neuropharmacology; 2012 Sep; 63(3):349-61. PubMed ID: 22534050
[TBL] [Abstract][Full Text] [Related]
27. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
[TBL] [Abstract][Full Text] [Related]
28. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.
Crews L; Patrick C; Adame A; Rockenstein E; Masliah E
Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CDK4, pRB, and E2F1 in ginsenoside Rg1 protecting rat cortical neurons from beta-amyloid-induced apoptosis.
Chen XC; Chen LM; Zhu YG; Fang F; Zhou YC; Zhao CH
Acta Pharmacol Sin; 2003 Dec; 24(12):1259-64. PubMed ID: 14653954
[TBL] [Abstract][Full Text] [Related]
30. Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.
Yang Y; Wang L; Zhang C; Guo Y; Li J; Wu C; Jiao J; Zheng H
Chem Biol Drug Des; 2022 Jun; 99(6):884-896. PubMed ID: 35313087
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and acetylcholine releasing effects of ginsenoside Rg1 in hippocampus of beta-amyloid model rats.
Liu Y; Gao Y; Li KX; Xue W
J Asian Nat Prod Res; 2019 Aug; 21(8):772-781. PubMed ID: 30501509
[TBL] [Abstract][Full Text] [Related]
32. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
34. [Ginsenoside-Rg1 inhibits cell apoptosis induced by beta amyloid].
Wei CB; Jia JP; Liang P; Guan YQ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(25):1763-6. PubMed ID: 19035088
[TBL] [Abstract][Full Text] [Related]
35. New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease.
Wu JJ; Yang Y; Wan Y; Xia J; Xu JF; Zhang L; Liu D; Chen L; Tang F; Ao H; Peng C
Biomed Pharmacother; 2022 Aug; 152():113207. PubMed ID: 35667236
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of ginsenoside Rg1 against oxygen-glucose deprivation in cultured hippocampal neurons.
He Q; Sun J; Wang Q; Wang W; He B
J Chin Med Assoc; 2014 Mar; 77(3):142-9. PubMed ID: 24548377
[TBL] [Abstract][Full Text] [Related]
37. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
Shi C; Viccaro K; Lee HG; Shah K
J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
39. [Mechanism of ginsenoside Rg1 regulating the activity of β secretase in N2a/APP695 cells].
Chen LM; Lin N; Zhang J; Zhu YG; Chen XC
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):330-5. PubMed ID: 22490838
[TBL] [Abstract][Full Text] [Related]
40. Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease.
Wu JJ; Zhang L; Liu D; Xia J; Yang Y; Tang F; Chen L; Ao H; Peng C
J Ethnopharmacol; 2024 Jan; 318(Pt B):116955. PubMed ID: 37536646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
